Skip to main content
Watch Insiders
LYEL filings

Corporate insider profile

Lynn Seely Filing Activity

Latest reported as President and CEO of Lyell Immunopharma, Inc. (LYEL).

Purchase filings
0
Reported companies
1
Net open-market value
-$161,942.74
Latest transaction
Aug 21, 2026

Affiliated corporations

Reported company relationships

LYELLatest reported

Lyell Immunopharma, Inc.

President and CEO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 21, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale9,589$15.54$149,013
Aug 10, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale390$14.34$5,593
May 11, 2026Lyell Immunopharma, Inc. (LYEL)President and CEOSale388$18.91$7,337